Then, through immunohistochemical analysis and an extensive literature review, we differentiated the patient’s tumor from various types of renal cancer and diagnosed it as TFEB/6p21/VEGFA-amplified renal cell carcinoma. This evidence concerns the gene VEGFA and neoplasm.